Cargando…
Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
Autores principales: | Kuscu, Ozlem Ozkan, Ergenoglu, Pinar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949026/ https://www.ncbi.nlm.nih.gov/pubmed/36844115 http://dx.doi.org/10.2478/rjaic-2021-0015 |
Ejemplares similares
-
“Tracheostomy healing time after decannulation”: can we improve it?
por: Özkan Kuşcu, Özlem, et al.
Publicado: (2022) -
Post-transplant patients with COVID-19 associated acute respiratory distress syndrome, a role for Tociluzumab: A case series
por: Ladna, M., et al.
Publicado: (2020) -
Immune thrombocytopenic purpura worsened by COVID-19
por: Kim, Chul Soo, et al.
Publicado: (2021) -
Immune thrombocytopenic purpura and COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2023) -
Immune thrombocytopenic purpura and COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2023)